Middle East And Africa Lipid Panel Testing Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2024 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
|
 TCAC |
% |
| Principaux acteurs du marché |
>Marché des tests de panel lipidique au Moyen-Orient et en Afrique, par produits et services (appareils, kits et services), mode de prescription (tests sur ordonnance et tests en vente libre), application ( hyperlipidémie , hypertriglycéridémie, hypercholestérolémie familiale, hypolipidémie, maladie de Tangier, athérosclérose et autres), utilisateur final (hôpitaux, cliniques spécialisées et cabinets de médecins, laboratoires de pathologie, cliniques de diagnostic, centres de chirurgie ambulatoire, laboratoires de référence, instituts universitaires et de recherche, et autres), canal de distribution (appel d'offres direct, pharmacie de détail, ventes en ligne et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et perspectives du marché des tests de panel lipidique au Moyen-Orient et en Afrique
La sensibilisation croissante aux tests de panel lipidique au Moyen-Orient et en Afrique a renforcé la demande pour le marché. L'augmentation des dépenses de santé pour de meilleurs services de santé contribue également à la croissance du marché. Les principaux acteurs du marché se concentrent sur le lancement et l'approbation de divers services au cours de cette période cruciale. En outre, l'augmentation des progrès en matière de processus et de techniques contribue également à la demande croissante de tests de panel lipidique.
Le marché des tests de panel lipidique au Moyen-Orient et en Afrique devrait croître au cours de l'année de prévision en raison de l'augmentation du nombre d'acteurs sur le marché et de la disponibilité de services avancés. Parallèlement à cela, les fabricants sont engagés dans l'activité de développement pour lancer de nouveaux services et des tests de panel lipidique efficaces et précis sur le marché. Le développement croissant des techniques de soins de santé avancées stimule encore la croissance du marché. Cependant, des difficultés telles que les réglementations strictes pour la production et la commercialisation de produits de test de panel lipidique pourraient entraver la croissance du marché des tests de panel lipidique au Moyen-Orient et en Afrique au cours de la période de prévision.
Data Bridge Market Research analyse que le marché des tests de panel lipidique au Moyen-Orient et en Afrique devrait atteindre la valeur de 791,90 millions USD d'ici 2030, à un TCAC de 5,8 % au cours de la période de prévision.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable de 2015 à 2020) |
|
Unités quantitatives |
Chiffre d'affaires en millions, volumes en unités, prix en USD |
|
Segments couverts |
Produits et services (dispositifs, kits et services), mode de prescription (tests sur ordonnance et tests en vente libre), application (hyperlipidémie, hypertriglycéridémie , hypercholestérolémie familiale, hypolipidémie, maladie de Tangier, athérosclérose et autres), utilisateur final (hôpitaux, cliniques spécialisées et cabinets médicaux, laboratoires de pathologie, cliniques de diagnostic, centres de chirurgie ambulatoire, laboratoires de référence, instituts universitaires et de recherche, et autres), canal de distribution (appel d'offres direct, pharmacie de détail, vente en ligne et autres) |
|
Pays couverts |
Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et reste du Moyen-Orient et de l'Afrique |
|
Acteurs du marché couverts |
Some major companies dealing in the Middle East and Africa lipid panel testing market are Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Subsidiary of Danaher), and Sekisui Diagnostics (A Part of SEKISUI Chemical Co. Ltd.) among others |
Middle East and Africa Lipid Panel Testing Market Definition
A lipid panel is a common blood test healthcare providers use to monitor and screen for cardiovascular disease risk. The panel includes three cholesterol measurements as well as a triglyceride measurement.
Healthcare providers use lipid panels to assess someone's cardiovascular health by analyzing cholesterol in their blood and to help diagnose other health conditions. The lipid panel assesses the presence of specific fat molecules known as lipids in the blood. It measures multiple substances as a panel test, including several cholesterol-containing molecules. The lipid panel assesses the risk of cardiovascular diseases such as heart disease, heart attack, and stroke in children and adults.
Middle East and Africa Lipid Panel Testing Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- INCREASING PREVALENCE OF CHRONIC DISEASES
A lipid panel is a common blood test used by healthcare providers to monitor and screen the risk of cardiovascular disease and other chronic diseases. The panel includes three measurements of cholesterol and a measurement of triglycerides. While providers & healthcare professionals mostly use lipid panels for screening or monitoring cholesterol levels. Providers sometimes use them as part of the diagnostic process for certain health conditions that can affect your lipid levels, including pancreatitis, chronic kidney disease, and hypothyroidism.
Thus, in conclusion, the rise in the number of chronic diseases such as cardiovascular diseases, chronic kidney disorders, liver diseases, and various other chronic diseases has led to an increase in the demand for lipid profiling with increasing market demand for lipid panel testing kits will drive the growth of the Middle East and Africa lipid panel testing market in coming years.
Restraint
- HIGH COST ASSOCIATED WITH TESTING PANELS
A lipid profile test is a lipid panel, cholesterol profile, or heart risk profile. This is a combination of blood tests that help measure levels of blood fats such as cholesterol and triglycerides. These cholesterol and triglycerides are good and bad types of fat.
The testing panels require a huge cost for the development process. As the concept needs to be locked down, the materials must be sourced, and it is important to consider lead times. Additionally, the process is time-consuming as the device design needs sufficient time to fully mature before entering the market.
Furthermore, any changes that must be re-verified will impact time. The growing advancements in biosensor assay formats and other complementary technologies demanded an effective investment for successful operations and a project risk management plan. Establishing R&D for conducting research entails high costs, leading to expensive devices. Thus, this factor is a major restrain for the Middle East and Africa lipid panel testing market.
Opportunity
GROWTH IN TECHNOLOGICAL ADVANCEMENTS
A lipid panel is a common blood test healthcare providers use to monitor and screen for cardiovascular disease risk. The panel includes three cholesterol measurements as well as a triglyceride measurement.
Technological developments in lipid panel testing result in additional accuracy, high sensitivity, higher success rate, and newer materials, depending on their use in different lipid panel testing. The commercializing of advanced technology-based lipid panel testing devices and products used for diagnostics and testing procedures has increased consumer demand, which propels the market's demand.
Thus, the technological advancements and development of the lipid panel testing method are expected to drive growth in the Middle East and Africa lipid panel testing market.
Challenge
LACK OF SKILLED & CERTIFIED PROFESSIONALS
The requirement for skilled and certified professionals is a big challenge for lipid panel testing. The demand for lipid panel testing for the diagnosis is increased due to increasing cases of obesity, cardiovascular diseases, and cholesterol Middle East and Africa. However, the fewer skilled professionals in the diagnostic center are hampering the market's growth.
The instruments, methods, and procedures of lipid panel testing diagnosis have been advanced, but there are certain gaps in standardization, equalization, and knowledge. Technicians face technical training gaps related to problems and adapt advanced methods safely to perform procedures efficiently. In lipid panel testing, skilled professionals are highly needed for method development, validation, operation, and troubleshooting.
Post COVID-19 Impact Analysis on Middle East and Africa Lipid Panel Testing Market
Covid-19 made a massive dent in the diagnostics sector with a steep fall in patient volumes since the beginning of 2020. The pandemic developed an eerie sense of fear among people, which eventually impacted hospital/clinic and lab visits. Regular checkups became cumbersome, stressful and time consuming. While the overall diagnostics sector seemed to have suffered a decline, the area of home diagnostics was the silver lining in the new scheme of things.
Recent Developments
- In October 2022, Eurofins Scientific, announced the commencement of the largest European biomonitoring projects for PFAS (polyfluoroalkyl) in blood Antwrep which is commissioned by the Agency for Care and Health of the Flemish Government. This product launch has helped the company in its product portfolio expansion.
- In December 2022, Laboratory Corporation of America Holdings, announced that it had begun the operations at a new, larger anatomic pathology and histology laboratory in Los Angeles. This new operations helped the company in expanding the company’s Middle East and Africa central laboratory capabilities.
Middle East and Africa Lipid Panel Testing Market Scope
Middle East and Africa lipid panel testing market is segmented into five notable segments such as product & services, prescription mode, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
PRODUCT & SERVICES
- DEVICES
- KITS
- SERVICES
On the basis of products & services, the Middle East and Africa lipid panel testing market is segmented into devices, kits and services.
PRESCRIPTION MODE
- PRESCRIPTION-BASED TESTING
- OTC-BASED TESTING
On the basis of prescription mode, the Middle East and Africa lipid panel testing market is segmented into prescription-based testing and OTC-based testing.
APPLICATION
- HYPERLIPIDEMIA
- HYPERTRIGLYCERIDEMIA
- FAMILIAL HYPERCHOLESTEROLEMIA
- HYPO LIPOPROTEINAMIA
- TANGIER DISEASE
- ATHEROSCLEROSIS
- OTHERS
On the basis of application, the Middle East and Africa lipid panel testing market is segmented into hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo lipoproteinemia, tangier disease, atherosclerosis, and others.
END USER
- HOSPITAL
- SPECIALTY CLINICS AND PHYSICIAN OFFICES
- PATHOLOGY LABORATORIES
- DIAGNOSTIC CLINICS
- AMBULATORY SURGICAL CENTERS
- REFERENCE LABORATORIES
- ACADEMIC AND RESEARCH INSTITUTES
- OTHERS
On the basis of end user, the Middle East and Africa lipid panel testing market is segmented into hospitals, specialty clinics & physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others.
DISTRIBUTION CHANNEL
- DIRECT TENDER
- RETAIL PHARMACY
- ONLINE SALES
- OTHERS
On the basis of distribution channel, the Middle East and Africa lipid panel testing market is segmented into direct tender, retail pharmacy, online sales, and others.
Analyse/perspectives régionales du marché des tests lipidiques au Moyen-Orient et en Afrique
Le marché des tests de panel lipidique au Moyen-Orient et en Afrique est classé en cinq segments notables : produits et services, mode de prescription, application, utilisateur final et canal de distribution.
Les pays couverts dans ce rapport de marché sont l’Afrique du Sud, l’Arabie saoudite, les Émirats arabes unis, l’Égypte, Israël et le reste du Moyen-Orient et de l’Afrique.
L'Afrique du Sud domine la région du Moyen-Orient et de l'Afrique en raison de la tendance croissante des clients à l'égard des processus technologiques avancés.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, les actes réglementaires et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques du Moyen-Orient et d'Afrique et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, ainsi que l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché des tests de panel lipidique au Moyen-Orient et en Afrique
Le paysage concurrentiel du marché des tests de panel lipidique au Moyen-Orient et en Afrique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement du produit, les approbations de produits, la largeur et la portée du produit, la domination de l'application, la courbe de survie du type de produit. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché des tests de panel lipidique au Moyen-Orient et en Afrique.
Français Certaines grandes entreprises opérant sur le marché des tests de panel lipidique au Moyen-Orient et en Afrique sont Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (filiale de Danaher) et Sekisui Diagnostics (une partie de SEKISUI Chemical Co. Ltd.) entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS & SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 PATENT ANALYSIS
5 INDUSTRIAL INSIGHTS
5.1 KEY PRICING STRATEGY
6 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING NUMBER OF CASES OF DYSLIPIDEMIA
7.1.3 RAPID CHANGES IN LIFESTYLE CHANGES LEAD TO LIPID DISORDERS
7.1.4 RISE IN PREFERENCE FOR HOMECARE TESTING IN LIPID PANEL TESTING
7.2 RESTRAINTS
7.2.1 STRICT GOVERNMENT REGULATIONS
7.2.2 HIGH COST ASSOCIATED WITH TESTING PANELS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
7.3.2 RISE IN THE PREVALENCE OF OBESITY AMONG PEOPLE
7.3.3 INCREASING ADOPTION OF POINT-OF-CARE LIPID PANEL TESTING
7.4 CHALLENGES
7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS
7.4.2 LACK OF STANDARDIZATION OF LIPID PANEL TESTING
8 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES
8.1 OVERVIEW
8.2 SERVICES
8.2.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
8.2.2 TOTAL CHOLESTEROL TEST
8.2.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
8.2.4 TRIGLYCERIDES/ VLDL TEST
8.2.5 NON-HDL CHOLESTEROL TEST
8.2.6 OTHERS
8.3 KITS
8.3.1 STRIPS
8.3.1.1 THREE-ANALYTE TEST STRIPS
8.3.1.2 DUAL-ANALYTE TEST STRIPS
8.3.1.3 SINGLE-ANALYTE TEST STRIPS
8.3.2 LANCETS
8.3.3 CONTROLS
8.3.3.1 MULTI-CHEMISTRY CONTROLS
8.3.3.2 HDL CHOLESTEROL CONTROLS
8.3.3.3 OTHERS
8.3.4 CAPILLARY TUBES
8.4 DEVICES
8.4.1 BY MODALITY
8.4.1.1 STANDALONE
8.4.1.2 HANDHELD
8.4.1.3 PORTABLE
8.4.2 BY TYPE
8.4.2.1 LABORATORY BASED
8.4.2.2 POINT OF CARE BASED
9 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 PRESCRIPTION-BASED TESTING
9.3 OTC-BASED TESTING
10 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 HYPERLIPIDEMIA
10.2.1 TOTAL CHOLESTEROL TEST
10.2.2 TRIGLYCERIDES/ VLDL TEST
10.2.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.2.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.2.5 NON-HDL CHOLESTEROL TEST
10.2.6 OTHERS
10.3 HYPERTRIGLYCERIDEMIA
10.3.1 TRIGLYCERIDES/ VLDL TEST
10.3.2 TOTAL CHOLESTEROL TEST
10.3.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.3.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.3.5 NON-HDL CHOLESTEROL TEST
10.3.6 OTHERS
10.4 ATHEROSCLEROSIS
10.4.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.4.2 TOTAL CHOLESTEROL TEST
10.4.3 TRIGLYCERIDES/ VLDL TEST
10.4.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.4.5 NON-HDL CHOLESTEROL TEST
10.4.6 OTHERS
10.5 FAMILIAL HYPERCHOLESTEROLEMIA
10.5.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.5.2 TOTAL CHOLESTEROL TEST
10.5.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.5.4 TRIGLYCERIDES/ VLDL TEST
10.5.5 NON-HDL CHOLESTEROL TEST
10.5.6 OTHERS
10.6 HYPO LIPOPROTEINEMIA
10.6.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.6.2 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.6.3 TRIGLYCERIDES/ VLDL TEST
10.6.4 TOTAL CHOLESTEROL TEST
10.6.5 NON-HDL CHOLESTEROL TEST
10.6.6 OTHERS
10.7 TANGIER DISEASE
10.7.1 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.7.2 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.7.3 TOTAL CHOLESTEROL TEST
10.7.4 TRIGLYCERIDES/ VLDL TEST
10.7.5 NON-HDL CHOLESTEROL TEST
10.7.6 OTHERS
10.8 OTHERS
11 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 PRIVATE
11.2.1.1.1 SERVICES
11.2.1.1.2 KITS
11.2.1.1.3 DEVICES
11.2.1.2 PUBLIC
11.2.1.2.1 SERVICES
11.2.1.2.2 KITS
11.2.1.2.3 DEVICES
11.2.2 BY TIER
11.2.2.1 TIER 1
11.2.2.1.1 SERVICES
11.2.2.1.2 KITS
11.2.2.1.3 DEVICES
11.2.2.2 TIER 2
11.2.2.2.1 SERVICES
11.2.2.2.2 KITS
11.2.2.2.3 DEVICES
11.2.2.3 TIER 3
11.2.2.3.1 SERVICES
11.2.2.3.2 KITS
11.2.2.3.3 DEVICES
11.3 DIAGNOSTIC CLINICS
11.3.1 SERVICES
11.3.2 KITS
11.3.3 DEVICES
11.4 SPECIALTY CLINICS & PHYSICIAN OFFICES
11.4.1 SERVICES
11.4.2 KITS
11.4.3 DEVICES
11.5 REFERENCE LABORATORIES
11.5.1 SERVICES
11.5.2 KITS
11.5.3 DEVICES
11.6 AMBULATORY SURGICAL CENTERS
11.6.1 SERVICES
11.6.2 KITS
11.6.3 DEVICES
11.7 PATHOLOGY LABORATORIES
11.7.1 SERVICES
11.7.2 KITS
11.7.3 DEVICES
11.8 ACADEMIC AND RESEARCH INSTITUTES
11.8.1 SERVICES
11.8.2 KITS
11.8.3 DEVICES
11.9 OTHERS
12 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.3.1 HOSPITAL PHARMACIES
12.3.2 DRUG STORES
12.3.3 OTHERS
12.4 ONLINE SALES
12.5 OTHERS
13 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 EGYPT
13.1.4 UAE
13.1.5 ISRAEL
13.1.6 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
15 SWOT ANALYSIS
16 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, COMPANY PROFILE
16.1 QUEST DIAGNOSTICS INCORPORATED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 EUROFINS SCIENTIFIC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 F. HOFFMANN-LA ROCHE LTD.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 RANDOX LABORATORIES LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ABBOTT
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 COMPANY SHARE ANALYSIS
16.6.4 PRODUCT PORTFOLIO
16.6.5 RECENT DEVELOPMENT
16.7 AWARENESS TECHNOLOGY, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ARUP LABORATORIES
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIO-RAD LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 BOSTON HEART DIAGNOSTICS CORPORATION
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 CPC DIAGNOSTICS
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 CRODA INTERNATIONAL PLC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 DIATRON
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 EKF DIAGNOSTICS
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 EVERLYWELL, INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 ELITECH GROUP
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 HORIBA MEDICAL
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 MYLAB BOX
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 NOVA BIOMEDICAL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PTS DIAGNOSTICS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 SIEMENS HEALTHCARE GMBH
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 SINOCARE
16.23.1 COMPANY SNAPSHOT
16.23.2 REVENUE ANALYSIS
16.23.3 PRODUCT PORTFOLIO
16.23.4 RECENT DEVELOPMENT
16.24 SD BIOSENSOR, INC.
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENT
16.25 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)
16.25.1 COMPANY SNAPSHOT
16.25.2 REVENUE ANALYSIS
16.25.3 PRODUCT PORTFOLIO
16.25.4 RECENT DEVELOPMENTS
16.26 SPARK DIAGNOSTICS PVT. LTD.
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 THE BELOW-MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID PANEL TESTING DEVICES OFFERED BY DIFFERENT MANUFACTURERS-
TABLE 2 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA SERVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA KITS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA PRESCRIPTION-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA OTC-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA DIRECT TENDER IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA ONLINE SALES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 61 MIDDLE EAST AND AFRICA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 MIDDLE EAST AND AFRICA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 MIDDLE EAST AND AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 65 MIDDLE EAST AND AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 MIDDLE EAST AND AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 67 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 68 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 MIDDLE EAST AND AFRICA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 MIDDLE EAST AND AFRICA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 MIDDLE EAST AND AFRICA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 MIDDLE EAST AND AFRICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 MIDDLE EAST AND AFRICA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 MIDDLE EAST AND AFRICA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 MIDDLE EAST AND AFRICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 MIDDLE EAST AND AFRICA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 MIDDLE EAST AND AFRICA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 MIDDLE EAST AND AFRICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 80 MIDDLE EAST AND AFRICA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 81 MIDDLE EAST AND AFRICA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 82 MIDDLE EAST AND AFRICA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 MIDDLE EAST AND AFRICA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 84 MIDDLE EAST AND AFRICA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 MIDDLE EAST AND AFRICA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 MIDDLE EAST AND AFRICA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 MIDDLE EAST AND AFRICA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 MIDDLE EAST AND AFRICA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 91 SOUTH AFRICA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 92 SOUTH AFRICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 93 SOUTH AFRICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 94 SOUTH AFRICA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 95 SOUTH AFRICA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 SOUTH AFRICA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 SOUTH AFRICA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 SOUTH AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 99 SOUTH AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 SOUTH AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 101 SOUTH AFRICA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 102 SOUTH AFRICA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 103 SOUTH AFRICA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 SOUTH AFRICA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 SOUTH AFRICA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 SOUTH AFRICA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 SOUTH AFRICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 SOUTH AFRICA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 SOUTH AFRICA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 110 SOUTH AFRICA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 SOUTH AFRICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 112 SOUTH AFRICA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 SOUTH AFRICA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 SOUTH AFRICA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 115 SOUTH AFRICA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 116 SOUTH AFRICA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 SOUTH AFRICA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 SOUTH AFRICA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 119 SOUTH AFRICA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 SOUTH AFRICA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 SOUTH AFRICA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 122 SOUTH AFRICA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 123 SOUTH AFRICA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 124 SOUTH AFRICA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 125 SOUTH AFRICA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 SAUDI ARABIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 127 SAUDI ARABIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 128 SAUDI ARABIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 129 SAUDI ARABIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 130 SAUDI ARABIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 SAUDI ARABIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 SAUDI ARABIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 SAUDI ARABIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 134 SAUDI ARABIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 135 SAUDI ARABIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 136 SAUDI ARABIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 137 SAUDI ARABIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 138 SAUDI ARABIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 SAUDI ARABIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 SAUDI ARABIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 SAUDI ARABIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 SAUDI ARABIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 SAUDI ARABIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 SAUDI ARABIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 145 SAUDI ARABIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 146 SAUDI ARABIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 147 SAUDI ARABIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 SAUDI ARABIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 SAUDI ARABIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 150 SAUDI ARABIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 SAUDI ARABIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 152 SAUDI ARABIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 153 SAUDI ARABIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 154 SAUDI ARABIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 155 SAUDI ARABIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 156 SAUDI ARABIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 SAUDI ARABIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 SAUDI ARABIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 SAUDI ARABIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 SAUDI ARABIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 161 EGYPT LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 162 EGYPT SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 163 EGYPT SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 164 EGYPT SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 165 EGYPT KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 166 EGYPT STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 EGYPT CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 168 EGYPT DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 169 EGYPT DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 EGYPT DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 171 EGYPT DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 172 EGYPT LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 173 EGYPT LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 EGYPT HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 EGYPT HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 EGYPT ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 EGYPT FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 178 EGYPT HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 EGYPT TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 180 EGYPT LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 181 EGYPT HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 EGYPT PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 EGYPT PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 EGYPT HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 185 EGYPT TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 EGYPT TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 187 EGYPT TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 188 EGYPT DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 189 EGYPT SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 190 EGYPT REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 EGYPT AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 EGYPT PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 EGYPT ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 194 EGYPT LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 195 EGYPT RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 196 UAE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 197 UAE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 198 UAE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 199 UAE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 200 UAE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 201 UAE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 202 UAE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 203 UAE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 204 UAE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 UAE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 206 UAE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 207 UAE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 208 UAE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 UAE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 210 UAE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 211 UAE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 212 UAE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 UAE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 UAE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 UAE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 UAE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 217 UAE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 218 UAE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 219 UAE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 220 UAE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 221 UAE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 222 UAE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 223 UAE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 224 UAE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 225 UAE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 UAE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 227 UAE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 228 UAE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 UAE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 230 UAE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 ISRAEL LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 232 ISRAEL SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 233 ISRAEL SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 234 ISRAEL SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 235 ISRAEL KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 236 ISRAEL STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 237 ISRAEL CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 238 ISRAEL DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 239 ISRAEL DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 ISRAEL DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 241 ISRAEL DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 242 ISRAEL LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 243 ISRAEL LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 ISRAEL HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 ISRAEL HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 ISRAEL ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 ISRAEL FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 ISRAEL HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 ISRAEL TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 ISRAEL LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 251 ISRAEL HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 ISRAEL PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 253 ISRAEL PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 ISRAEL HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 255 ISRAEL TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 ISRAEL TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 ISRAEL TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 258 ISRAEL DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 ISRAEL SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 260 ISRAEL REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 ISRAEL AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 262 ISRAEL PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 263 ISRAEL ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 264 ISRAEL LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 265 ISRAEL RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 266 REST OF MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET IN THE FORECAST PERIOD
FIGURE 12 THE PRODUCTS & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET
FIGURE 14 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2022
FIGURE 15 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2022
FIGURE 19 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY APPLICATION, 2022
FIGURE 23 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY END USER, 2022
FIGURE 27 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET: SNAPSHOT (2022)
FIGURE 35 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET: BY COUNTRY (2022)
FIGURE 36 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 MIDDLE EAST AND AFRICA LIPID PANEL TESTING MARKET: PRODUCTS & SERVICES (2023-2030)
FIGURE 39 MIDDLE EAST & AFRICA LIPID PANEL TESTING MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
